SCHEMBL14855591

SCHEMBL14855591

O=[C]N(c1ccccc1)C1CCC1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 4/20 0.41
KMT2A Q03164 4/20 0.41
ALDH1A1 P00352 3/20 0.41
KDM4E B2RXH2 2/20 0.41
NPC1 O15118 1/20 0.41
MITF O75030 1/20 0.41
RAB9A P51151 1/20 0.41
PAX8 Q06710 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
TRPM8 Q7Z2W7 2/20 0.38
ESR1 P03372 1/20 0.38
KCNA3 P22001 1/20 0.36
HTT P42858 2/20 0.35
ATM Q13315 1/20 0.34
USP2 O75604 1/20 0.34
HPGD P15428 1/20 0.34
HSD17B10 Q99714 1/20 0.34
PKM P14618 1/20 0.34
CHRM2 P08172 1/20 0.34
CHRM3 P20309 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14855771 0.98 MEN1 (0.44) MEN1KMT2AALDH1A1KDM4ENPC1
SCHEMBL2393892 0.96 MEN1 (0.46) MEN1KMT2AALDH1A1KDM4ENPC1
SCHEMBL14855820 0.96 MEN1 (0.46) MEN1KMT2AALDH1A1KDM4ENPC1
SCHEMBL3245653 0.94 HTT (0.36) MEN1KMT2AALDH1A1KDM4ENPC1
SCHEMBL8487546 0.85 SLC6A4 (0.41) MEN1KMT2ALMNA
SCHEMBL4118367 0.77 CYP2C9 (0.40) MEN1KMT2AALDH1A1KDM4ENPC1
SCHEMBL3252095 0.76 KDM4E (0.42) MEN1KMT2AALDH1A1KDM4ENPC1
SCHEMBL30036856 0.70 KCNA3 (0.47) MEN1KMT2AALDH1A1KDM4ENPC1
SCHEMBL28581310 0.69 KDM4E (0.46) MEN1KMT2AALDH1A1KDM4ENPC1
SCHEMBL218047 0.69 KCNA3 (0.50) MEN1KMT2AALDH1A1KDM4ENPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130165446-A1 BENZO-OR PYRIDO-IMIDAZOLE DERIVATIVE HORIKOSHI, HIROYOSHI (CA) 2013-06-27 US disclosed
EP-2581373-A1 BENZO- OR PYRIDO-IMIDAZOLE DERIVATIVE Fujita, Takashi (JP) 2013-04-17 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130165446-A1 BENZO-OR PYRIDO-IMIDAZOLE DERIVATIVE PPARG, PPARA, PPARD MEN1 4822/4885KMT2A 1996/4885ALDH1A1 1612/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.